TMDX TransMedics Group, Inc. Stock Quote

TMDX [NASD]

Index	-	P/E	-	EPS (ttm)	-1.71	Insider Own	0.20%	Shs Outstand	27.98M	Perf Week	3.37%
Market Cap	1.51B	Forward P/E	-	EPS next Y	-1.22	Insider Trans	-78.42%	Shs Float	26.74M	Perf Month	42.51%
Income	-47.70M	PEG	-	EPS next Q	-0.42	Inst Own	72.00%	Short Float	5.90%	Perf Quarter	62.96%
Sales	51.40M	P/S	29.37	EPS this Y	-37.60%	Inst Trans	1.31%	Short Ratio	4.59	Perf Half Y	217.12%
Book/sh	1.82	P/B	26.15	EPS next Y	45.80%	ROA	-37.60%	Target Price	47.50	Perf Year	63.80%
Cash/sh	1.83	P/C	25.99	EPS next 5Y	-	ROE	-74.20%	52W Range	10.00 - 49.27	Perf YTD	148.43%
Dividend	-	P/FCF	-	EPS past 5Y	-6.10%	ROI	-38.30%	52W High	-3.39%	Beta	-
Dividend %	-	Quick Ratio	3.40	Sales past 5Y	37.30%	Gross Margin	72.30%	52W Low	376.00%	ATR	3.09
Employees	148	Current Ratio	4.20	Sales Q/Q	150.00%	Oper. Margin	-81.90%	RSI (14)	67.83	Volatility	6.51% 8.00%
Optionable	Yes	Debt/Eq	0.70	EPS Q/Q	-6.60%	Profit Margin	-92.80%	Rel Volume	0.79	Prev Close	47.00
Shortable	Yes	LT Debt/Eq	0.70	Earnings	Aug 01 AMC	Payout	-	Avg Volume	343.89K	Price	47.60
Recom	2.00	SMA20	19.44%	SMA50	39.75%	SMA200	90.82%	Volume	271,474	Change	1.28%

Aug-02-22

Upgrade

JP Morgan

Neutral → Overweight

$48

Oct-08-20

Downgrade

JP Morgan

Overweight → Neutral

$15

Apr-07-20

Initiated

Oppenheimer

Outperform

$25

May-28-19

Initiated

Morgan Stanley

Equal-Weight

May-28-19

Initiated

JP Morgan

Overweight

May-28-19

Initiated

Cowen

Outperform

May-28-19

Initiated

Canaccord Genuity

Buy

Aug-04-22 08:19PM	TransMedics Announces Upsize and Pricing of Public Offering of Common Stock PR Newswire
Aug-03-22 04:36PM	TransMedics Announces Proposed Public Offering of Common Stock PR Newswire +5.61%
Aug-01-22 06:15PM	TransMedics (TMDX) Reports Q2 Loss, Tops Revenue Estimates Zacks
04:05PM	TransMedics Reports Second Quarter 2022 Financial Results PR Newswire
Jul-26-22 04:05PM	TransMedics to Present at the Canaccord Genuity 42nd Annual Growth Conference PR Newswire
Jul-18-22 04:05PM	TransMedics to Report Second Quarter 2022 Financial Results on August 1, 2022 PR Newswire
Jul-17-22 08:04AM	A TransMedics Group, Inc. (NASDAQ:TMDX) insider increased their holdings by 49% last year Simply Wall St.
Jul-14-22 10:45AM	Bear Market Winners: 3 Healthcare Stocks That Have Soared More Than 30% This Year Motley Fool +5.21%
Jun-25-22 09:00AM	Up 1,000% in 5 Years? Here Are 3 Stocks That Can Run That High Motley Fool
Jun-24-22 06:14AM	Is TransMedics Group (NASDAQ:TMDX) A Risky Investment? Simply Wall St.
Jun-03-22 04:05PM	TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire
May-30-22 08:20AM	Investors in TransMedics Group (NASDAQ:TMDX) have made a return of 17% over the past year Simply Wall St.
May-07-22 08:08AM	Analysts Are Betting On TransMedics Group, Inc. (NASDAQ:TMDX) With A Big Upgrade This Week Simply Wall St.
May-04-22 11:17AM	TransMedics Stock Skyrockets On Increased 2022 Guidance Benzinga +40.33%
May-03-22 05:45PM	TransMedics (TMDX) Reports Q1 Loss, Tops Revenue Estimates Zacks
04:05PM	TransMedics Reports First Quarter 2022 Financial Results PR Newswire
Apr-28-22 07:00AM	TransMedics Receives FDA PMA Approval of OCS DCD Heart Indication PR Newswire +6.52%
Apr-21-22 04:05PM	TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire
Apr-19-22 06:04PM	TransMedics to Report First Quarter 2022 Financial Results on May 3, 2022 PR Newswire
04:05PM	TransMedics Announces the Presentation of New OCS Heart and OCS Lung Clinical Data at the International Society of Heart and Lung Transplantation 2022 Annual Meeting PR Newswire
Apr-14-22 07:27AM	Are Institutions Heavily Invested In TransMedics Group, Inc.'s (NASDAQ:TMDX) Shares? Simply Wall St. -5.25%
Mar-21-22 07:30AM	TransMedics (TMDX) Soars 9.9%: Is Further Upside Left in the Stock? Zacks -5.01%
Mar-01-22 04:05PM	TransMedics to Present at the Oppenheimer's 32nd Annual Healthcare Conference PR Newswire
Feb-28-22 04:26AM	TransMedics Group, Inc. (NASDAQ:TMDX) Analysts Just Cut Their EPS Forecasts Substantially Simply Wall St. +8.49%
Feb-25-22 04:05PM	TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire
Feb-23-22 06:05PM	TransMedics (TMDX) Reports Q4 Loss, Tops Revenue Estimates Zacks -5.27%
04:05PM	TransMedics Reports Fourth Quarter and Full Year 2021 Financial Results PR Newswire
Feb-22-22 04:05PM	TransMedics to Present at the Cowen 42nd Annual Healthcare Conference PR Newswire -7.59%
Feb-21-22 10:58AM	Analysts Expect Breakeven For TransMedics Group, Inc. (NASDAQ:TMDX) Before Long Simply Wall St.
Feb-09-22 04:05PM	TransMedics to Report Fourth Quarter and Full Year 2021 Financial Results on February 23, 2022 PR Newswire
Feb-08-22 02:38PM	Skylands Capital, LLC Buys Grand Canyon Education Inc, Owens-Corning Inc, T-Mobile US Inc, ... GuruFocus.com
Jan-19-22 09:38AM	Signature Wealth Management Partners, LLC Buys Verizon Communications Inc, Lumen Technologies ... GuruFocus.com
Jan-14-22 09:32AM	Is TransMedics Group (NASDAQ:TMDX) A Risky Investment? Simply Wall St.
Jan-05-22 06:41PM	TransMedics Announces Publication of OCS Liver PROTECT Trial Results in JAMA Surgery PR Newswire -6.57%
Dec-24-21 11:38PM	Federated Hermes Clover Small Value Fund Buys Gray Television Inc, Verint Systems Inc, Veritex ... GuruFocus.com
Dec-22-21 07:00AM	TransMedics to Present at the 40th Annual J.P. Morgan Healthcare Conference PR Newswire
Dec-17-21 08:38PM	Baillie Gifford Funds Buys Sprout Social Inc, Upwork Inc, TransMedics Group Inc, Sells Cloudera ... GuruFocus.com
Dec-01-21 05:09AM	Insider Buying: The TransMedics Group, Inc. (NASDAQ:TMDX) Independent Director Just Bought 49% More Shares Simply Wall St.
Nov-11-21 04:05PM	TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire
Nov-09-21 06:15PM	TransMedics (TMDX) Reports Q3 Loss, Lags Revenue Estimates Zacks
04:05PM	TransMedics Reports Third Quarter 2021 Financial Results PR Newswire
Nov-04-21 04:05PM	TransMedics to Participate in the Canaccord Genuity Virtual MedTech, Diagnostics, and Digital Health & Services Forum PR Newswire +6.73%
09:57AM	TransMedics Reports Positive Data From OCS DCD Heart Trial Benzinga
07:00AM	TransMedics Announces Positive Top Line Results From the U.S. Randomized OCS DCD Heart Trial PR Newswire
Nov-02-21 03:01PM	TransMedics (TMDX) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release Zacks
Oct-26-21 04:05PM	TransMedics to Report Third Quarter 2021 Financial Results on November 9, 2021 PR Newswire
01:20PM	Do Institutions Own TransMedics Group, Inc. (NASDAQ:TMDX) Shares? Simply Wall St.
Sep-29-21 07:00AM	TransMedics Receives FDA Approval for its OCS Liver System for Preservation and Assessment of Donor Livers for Transplantation PR Newswire
Sep-20-21 01:08PM	TransMedics Group's (NASDAQ:TMDX) investors will be pleased with their stellar 101% return over the last year Simply Wall St. -7.13%
Sep-10-21 04:59PM	Chief Financial Officer Of Transmedics Group Trades $356.70 Thousand In Company Stock Benzinga
Sep-08-21 11:17AM	TransMedics (TMDX) Receives FDA Nod for OCS Heart System Zacks
Sep-07-21 11:11AM	TransMedics' OCS Heart System Scores FDA Approval Benzinga
07:00AM	TransMedics Receives FDA Approval for its OCS Heart System Enabling Broader Utilization of Donor Hearts for Transplantation in the U.S. PR Newswire
Aug-26-21 04:05PM	TransMedics to Participate in the Morgan Stanley 19th Annual Global Healthcare Conference PR Newswire +7.65%
Aug-09-21 04:05PM	TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire
Aug-05-21 08:35PM	TransMedics (TMDX) Reports Q2 Loss, Tops Revenue Estimates Zacks
04:05PM	TransMedics Reports Second Quarter 2021 Financial Results PR Newswire
08:24AM	TransMedics Group (NASDAQ:TMDX) Has Debt But No Earnings; Should You Worry? Simply Wall St.
Jul-29-21 06:05PM	TransMedics Receives FDA Clearance of OCS Lung Solution for Cold Preservation of Lungs PR Newswire
03:05PM	Will TransMedics (TMDX) Report Negative Earnings Next Week? What You Should Know Zacks
Jul-28-21 04:05PM	TransMedics to Participate in the Canaccord Genuity 41st Annual Growth Conference PR Newswire
Jul-22-21 04:05PM	TransMedics to Report Second Quarter 2021 Financial Results on August 5, 2021 PR Newswire
Jul-14-21 09:00PM	TransMedics Announces Positive FDA Advisory Committee Vote for the OCS Liver System PR Newswire
07:30AM	TransMedics Group's stock is halted in advance of FDA committee meeting MarketWatch
07:05AM	TransMedics Stock Trading Halted Today; FDA Advisory Committee to Review Premarket Approval Application for the OCS Liver System PR Newswire
Jun-14-21 11:35AM	Here is What Hedge Funds Think About TransMedics Group, Inc. (TMDX) Insider Monkey
Jun-10-21 10:35AM	TransMedics Announces Scheduling of OCS Liver FDA Advisory Committee Meeting PR Newswire
Jun-08-21 04:05PM	TransMedics Announces Presentation of OCS Liver PROTECT Trial Results and is Recognized as Winner of The People's Choice Award for Most Impactful Presentation at the American Transplant Congress (ATC 2021) PR Newswire
May-26-21 07:00AM	Anavex Life Sciences Announces Appointment of Ms Jiong Ma, PhD to Board of Directors GlobeNewswire
May-04-21 06:35PM	TransMedics (TMDX) Reports Q1 Loss, Tops Revenue Estimates Zacks
04:01PM	TransMedics Reports First Quarter 2021 Financial Results PR Newswire
02:30PM	TransMedics Group, Inc. to Host Earnings Call ACCESSWIRE
Apr-22-21 07:43AM	1 Feel-Good Healthcare Stock That Could Turn Your Tax Return Into Riches Motley Fool
Apr-20-21 04:05PM	TransMedics to Report First Quarter 2021 Financial Results on May 4, 2021 PR Newswire
Apr-15-21 05:30AM	TransMedics Group's Charts Are Pointed Lower TheStreet.com -5.29%
Apr-09-21 07:41AM	What Type Of Shareholders Own The Most Number of TransMedics Group, Inc. (NASDAQ:TMDX) Shares? Simply Wall St.
Apr-07-21 08:50AM	TransMedics Stock Is Trading Higher After FDA Adcom Votes In Favor Of Its OCS Heart System Benzinga
Apr-06-21 10:20PM	TransMedics Announces Positive FDA Advisory Committee Vote for OCS Heart System PR Newswire
05:30PM	How Jonah Lupton Expects TransMedics Group Stock To React To FDA Decision Benzinga
07:05AM	TransMedics Stock Trading Halted Today; FDA Advisory Committee to Review Premarket Approval Application for the OCS Heart System PR Newswire
Mar-24-21 04:05PM	TransMedics Appoints Stephanie Lovell to Board of Directors PR Newswire -5.91%
Mar-12-21 06:01AM	Got $2,000? These 3 Unstoppable Stocks Could More Than Double Your Money Motley Fool
Mar-10-21 01:00PM	3 Healthcare Companies Worth a Look Motley Fool
Mar-04-21 12:29AM	US$40.80 - That's What Analysts Think TransMedics Group, Inc. (NASDAQ:TMDX) Is Worth After These Results Simply Wall St. -14.52%
Mar-02-21 05:35PM	TransMedics (TMDX) Reports Q4 Loss, Tops Revenue Estimates Zacks +9.58%
04:38PM	TransMedics Group: Q4 Earnings Insights Benzinga
04:01PM	TransMedics Reports Fourth Quarter and Full Year 2020 Financial Results PR Newswire
02:30PM	TransMedics Group, Inc. to Host Earnings Call ACCESSWIRE
Mar-01-21 04:15PM	TransMedics Announces Scheduling of OCS Heart FDA Advisory Committee Meeting PR Newswire
Feb-16-21 04:05PM	TransMedics to Present at the Cowen 41st Annual Healthcare Conference PR Newswire -6.26%
04:01PM	TransMedics to Report Fourth Quarter and Full Year 2020 Financial Results on March 2, 2021 PR Newswire
Feb-05-21 08:44AM	Did You Miss TransMedics Group's (NASDAQ:TMDX) 31% Share Price Gain? Simply Wall St.
Dec-24-20 08:00AM	TransMedics to Present at the 39th Annual J.P. Morgan Healthcare Conference PR Newswire
Dec-23-20 04:01PM	TransMedics Appoints Merilee Raines to Board of Directors PR Newswire
Dec-07-20 04:06PM	Is TMDX A Good Stock To Buy Now? Insider Monkey
Nov-04-20 08:31PM	TransMedics Group, Inc. (TMDX) Q3 2020 Earnings Call Transcript Motley Fool
06:45PM	TransMedics (TMDX) Reports Q3 Loss, Tops Revenue Estimates Zacks
04:01PM	TransMedics Reports Third Quarter 2020 Financial Results PR Newswire
02:30PM	TransMedics Group, Inc. to Host Earnings Call ACCESSWIRE
Oct-29-20 04:02PM	TransMedics to Participate in Upcoming Virtual Investor Conferences PR Newswire

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for extracorporeal perfusion and preservation of donor hearts; and OCS Liver for the preservation of donor livers. The company was founded in 1998 and is headquartered in Andover, Massachusetts.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Hassanein Waleed H	President & CEO	Aug 12	Sale	48.00	7,000	336,000	486,285	Aug 15 05:50 PM
Hassanein Waleed H	President & CEO	Aug 11	Sale	46.74	12,929	604,301	493,285	Aug 15 05:50 PM
Carey John F	VP of Operations	Aug 01	Option Exercise	2.21	3,000	6,630	3,771	Aug 01 08:40 PM
Carey John F	VP of Operations	Aug 01	Sale	41.27	3,000	123,802	771	Aug 01 08:40 PM
Khayal Tamer I	Chief Commercial Officer	Jul 29	Option Exercise	1.40	13,504	18,880	59,580	Aug 01 08:30 PM
Carey John F	VP of Operations	Jul 29	Option Exercise	7.86	4,000	31,434	4,771	Aug 01 08:40 PM
Carey John F	VP of Operations	Jul 29	Sale	40.01	4,000	160,040	771	Aug 01 08:40 PM
Khayal Tamer I	Chief Commercial Officer	Jul 29	Sale	40.01	13,504	540,295	46,076	Aug 01 08:30 PM
TOBIN JAMES R	Director	Jul 29	Sale	39.98	48,515	1,939,630	253,591	Aug 01 08:30 PM
Carey John F	VP of Operations	Jul 20	Option Exercise	13.99	1,500	20,992	1,879	Jul 22 05:00 PM
Carey John F	VP of Operations	Jul 20	Sale	34.57	1,500	51,855	379	Jul 22 05:00 PM
Carey John F	VP of Operations	Jul 11	Option Exercise	16.14	1,500	24,210	1,879	Jul 12 05:27 PM
Carey John F	VP of Operations	Jul 11	Sale	32.98	1,500	49,470	379	Jul 12 05:27 PM
Khayal Tamer I	Chief Commercial Officer	Jul 05	Option Exercise	0.28	13,504	3,781	59,580	Jul 06 06:17 PM
Gordon Stephen	Chief Financial Officer	Jul 05	Option Exercise	2.21	10,000	22,100	15,714	Jul 06 06:19 PM
Khayal Tamer I	Chief Commercial Officer	Jul 05	Sale	35.06	13,504	473,450	46,076	Jul 06 06:17 PM
Gordon Stephen	Chief Financial Officer	Jul 05	Sale	35.00	10,000	350,000	5,714	Jul 06 06:19 PM
TOBIN JAMES R	Director	Jul 05	Sale	35.00	48,515	1,698,025	302,106	Jul 06 06:17 PM
Carey John F	VP of Operations	Jun 28	Option Exercise	0.28	2,724	763	3,103	Jun 29 06:05 PM
Carey John F	VP of Operations	Jun 28	Sale	32.87	2,724	89,538	379	Jun 29 06:05 PM
Carey John F	VP of Operations	Jun 27	Option Exercise	0.28	3,320	930	3,699	Jun 27 07:59 PM
Carey John F	VP of Operations	Jun 27	Sale	32.59	3,320	108,199	379	Jun 27 07:59 PM
Carey John F	VP of Operations	Jun 24	Option Exercise	0.28	2,956	828	3,335	Jun 27 07:59 PM
Carey John F	VP of Operations	Jun 24	Sale	32.57	2,956	96,277	379	Jun 27 07:59 PM
Carey John F	VP of Operations	Jun 01	Option Exercise	0.28	1,500	420	1,879	Jun 03 05:00 PM
Carey John F	VP of Operations	Jun 01	Sale	28.19	1,500	42,279	379	Jun 03 05:00 PM
Carey John F	VP of Operations	May 04	Option Exercise	0.28	1,500	420	1,879	May 06 04:05 PM
TOBIN JAMES R	Director	May 04	Sale	29.94	48,516	1,452,569	350,621	May 06 04:05 PM
Carey John F	VP of Operations	May 04	Sale	25.31	1,500	37,965	379	May 06 04:05 PM
Carey John F	VP of Operations	Apr 01	Option Exercise	0.28	1,500	420	1,879	Apr 04 06:30 PM
Carey John F	VP of Operations	Apr 01	Sale	26.85	1,500	40,275	379	Apr 04 06:30 PM
Carey John F	VP of Operations	Mar 28	Option Exercise	10.85	4,500	48,827	4,879	Mar 30 07:19 PM
Carey John F	VP of Operations	Mar 28	Sale	25.01	4,500	112,545	379	Mar 30 07:19 PM
Hassanein Waleed H	President & CEO	Jan 06	Option Exercise	0.28	122,371	34,264	526,214	Jan 07 05:00 PM
Provost Miriam	VP of US Regulatory & FDA Rel.	Dec 23	Option Exercise	3.22	884	2,846	9,438	Dec 28 04:30 PM
KANIA EDWIN M JR	Director	Nov 29	Buy	22.56	100,000	2,256,215	302,893	Nov 30 04:15 PM
Carey John F	VP of Operations	Nov 01	Option Exercise	2.21	1,680	3,713	1,680	Nov 02 05:45 PM
Carey John F	VP of Operations	Nov 01	Sale	28.16	1,680	47,309	0	Nov 02 05:45 PM
Carey John F	VP of Operations	Oct 01	Option Exercise	2.21	1,680	3,713	1,680	Oct 05 04:52 PM
Carey John F	VP of Operations	Oct 01	Sale	32.33	1,680	54,317	0	Oct 05 04:52 PM
Provost Miriam	VP of US Regulatory & FDA Rel.	Sep 15	Option Exercise	16.14	5,625	90,788	12,431	Sep 17 04:34 PM
Provost Miriam	VP of US Regulatory & FDA Rel.	Sep 15	Sale	31.34	3,877	121,505	8,554	Sep 17 04:34 PM
Gordon Stephen	Chief Financial Officer	Sep 07	Option Exercise	0.67	10,000	6,700	15,714	Sep 09 06:14 PM
Khayal Tamer I	Chief Commercial Officer	Sep 07	Option Exercise	0.28	3,941	1,103	50,017	Sep 09 06:25 PM
Gordon Stephen	Chief Financial Officer	Sep 07	Sale	35.00	10,000	350,000	5,714	Sep 09 06:14 PM
Khayal Tamer I	Chief Commercial Officer	Sep 07	Sale	35.08	3,941	138,250	46,076	Sep 09 06:25 PM
Carey John F	VP of Operations	Sep 01	Option Exercise	2.21	1,680	3,713	1,680	Sep 03 05:14 PM
Carey John F	VP of Operations	Sep 01	Sale	31.98	1,680	53,734	0	Sep 03 05:14 PM
Sullivan John F	VP of Quality & Engineering	Aug 30	Option Exercise	0.28	3,200	896	14,273	Sep 01 05:04 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience